SelectScience
Join Free
Accelerating Science
NewsLife Sciences

GSTS to host 2nd Innovation Academy on Personalized Medicine

29 Nov 2013
Sonia Nicholas
Managing Editor and Clinical Lead

Industry news

Following the success of the inaugural event, GSTS will host the 2nd Innovation Academy on 6 December 2013 at The Royal Institution of Great Britain, London. The theme for the event is ‘Personalized medicine: Today’s reality, not just a promise for tomorrow’.

Experts in clinical science will provide insightful presentations on applications where diagnostics are already in use to provide personalized treatment. These will form three streams: therapeutic drug monitoring, infectious disease and transplantation medicine, and oncology. Fiona Carragher, Deputy Chief Scientific Officer, NHS England, will open the meeting.

Dr Dominic Harrington, Scientific Director and co-chair of the event, said, “The response to the 1st Innovation Academy was extremely positive. Clinical service is integral to everything we do at GSTS, and the Innovation Academy provides a forum for senior scientists and clinicians from across the GSTS and KingsPath partnership, to share and discuss new developments and examples of best practice.”

As the UK’s leading independent provider of pathology services, GSTS and King’s College Pathology LLP provide pathology services that make a real difference to patient care. Scientists at the Innovation Academy will showcase developments in topics such as personalizing therapy for inflammatory bowel disease, emerging technologies in virology, and patient selection for kinase inhibition in cancer.

To find out more about innovation at GSTS and KingsPath, please follow the company website link below.

To register for the 2nd Innovation Academy, email innovationacademy@gsts.com

Tags

Genome AnalysisGenomics, the study of genomes, includes functional genomics, evolutionary genomics and comparative genomics. There are many genomic technologies such as DNA sequencing of whole genomes, computational biology and bioinformatics. DNA and nucleic acids must be isolated and concentrated from cells for analysis with kits, automated analyzers and software. Other useful technologies for studying genomics include PCR, microarrays and electrophoresis.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Precision MedicinePrecision medicine refers to the idea of customized healthcare, where medical decisions and treatments are tailored to the individual patient. Molecular diagnostics, companion diagnostics and Next Generation Sequencing (NGS) play a pivotal role in this approach.

Related articles